BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 30784952)

  • 21. Prescription opioid use among individuals with serious mental illness.
    Spivak S; Cullen B; Eaton W; Nugent K; Spivak A; Fenton A; Rodriguez K; Mojtabai R
    Psychiatry Res; 2018 Sep; 267():85-87. PubMed ID: 29886275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship Between Residential Mobility and Behavioral Health Service Use in a National Sample of Adults With Mental Health and/or Substance Abuse Problems.
    Yuan Y; Manuel JI
    J Dual Diagn; 2018; 14(4):201-210. PubMed ID: 30303466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric and Substance Use Comorbidity in Treatment-Seeking Injection Opioid Users Referred From Syringe Exchange.
    Kidorf M; Solazzo S; Yan H; Brooner RK
    J Dual Diagn; 2018; 14(4):193-200. PubMed ID: 30332349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.
    Watkins KE; Paddock SM; Hudson TJ; Ounpraseuth S; Schrader AM; Hepner KA; Sullivan G
    J Subst Abuse Treat; 2016 Oct; 69():1-8. PubMed ID: 27568504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015-2018.
    Ali MM; Dubenitz J
    J Subst Abuse Treat; 2021 Nov; 130():108413. PubMed ID: 34118704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of co-occurring disorders in criminal recidivism and psychiatric recovery among adults with opioid use disorder and criminal-legal involvement: A statewide retrospective cohort study.
    Lawson SG; Foudray CMA; Lowder EM; Ray B; Carey KL
    J Subst Use Addict Treat; 2024 Jan; 156():209192. PubMed ID: 37866440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US.
    Han B; Jones CM; Einstein EB; Compton WM
    JAMA Netw Open; 2021 Oct; 4(10):e2129409. PubMed ID: 34652446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of criminal justice system involvement among people with co-occurring severe mental illness and substance use disorder.
    Prince JD; Wald C
    Int J Law Psychiatry; 2018; 58():1-8. PubMed ID: 29852999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders.
    Votaw VR; Witkiewitz K; Valeri L; Bogunovic O; McHugh RK
    Addict Behav; 2019 Jan; 88():48-55. PubMed ID: 30142484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double trouble: Psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality.
    Bogdanowicz KM; Stewart R; Broadbent M; Hatch SL; Hotopf M; Strang J; Hayes RD
    Drug Alcohol Depend; 2015 Mar; 148():85-92. PubMed ID: 25578253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
    De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R
    Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429
    [No Abstract]   [Full Text] [Related]  

  • 33. Diverse diagnostic profiles associated with prescription opioid use disorder in a nationwide sample: One crisis, multiple needs.
    De Nadai AS; Little TB; McCabe SE; Schepis TS
    J Consult Clin Psychol; 2019 Oct; 87(10):849-858. PubMed ID: 31556662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
    Havassy BE; Arns PG
    Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.
    Timko C; Harris AHS; Jannausch M; Ilgen M
    Drug Alcohol Depend; 2019 Jan; 194():230-237. PubMed ID: 30466040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polydrug use disorders in individuals with opioid use disorder.
    Hassan AN; Le Foll B
    Drug Alcohol Depend; 2019 May; 198():28-33. PubMed ID: 30877954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services.
    Weaver T; Madden P; Charles V; Stimson G; Renton A; Tyrer P; Barnes T; Bench C; Middleton H; Wright N; Paterson S; Shanahan W; Seivewright N; Ford C;
    Br J Psychiatry; 2003 Oct; 183():304-13. PubMed ID: 14519608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance use and internalizing symptoms among high school students and access to health care services: results from a population-based study.
    Cheung AH; Cook S; Kozloff N; Chee JN; Mann RE; Boak A
    Can J Public Health; 2019 Feb; 110(1):85-92. PubMed ID: 30406338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.
    Subramaniam GA; Stitzer MA
    Drug Alcohol Depend; 2009 Apr; 101(1-2):13-9. PubMed ID: 19081205
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.